Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
An Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors
Apply
HCB301
An Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step